Interestingly, a growing body of research has discovered that DPP-4 inhibitors might prevent a range of cardiovascular conditions, including HF, coronary atherosclerosis, calcified aortic valve disease, and hypertension [13]. This evidence concerns the gene DPP4 and hypertensive disorder.